These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 8225374)

  • 1. Chronic allograft rejection.
    Häyry P; Isoniemi H; Yilmaz S; Mennander A; Lemström K; Räisänen-Sokolowski A; Koskinen P; Ustinov J; Lautenschlager I; Taskinen E
    Immunol Rev; 1993 Aug; 134():33-81. PubMed ID: 8225374
    [No Abstract]   [Full Text] [Related]  

  • 2. Animal models of chronic heart and kidney allograft rejection.
    Paul LC
    Transplant Proc; 1993 Apr; 25(2):2080-1. PubMed ID: 8470277
    [No Abstract]   [Full Text] [Related]  

  • 3. Pharmacotherapeutic approach to prevent or treat chronic allograft nephropathy.
    Scholten EM; de Fijter JW; Paul LC
    Curr Drug Targets Cardiovasc Haematol Disord; 2002 Dec; 2(2):79-96. PubMed ID: 12769650
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rapamycin and cyclosporine A treatment: a novel regimen to prevent chronic allograft rejection in sensitized hosts.
    Wasowska B; Hancock WW; Onodera K; Korom S; Stadlbauer TH; Zheng XX; Strom TB; Kupiec-Weglinski JW
    Transplant Proc; 1997; 29(1-2):333. PubMed ID: 9123026
    [No Abstract]   [Full Text] [Related]  

  • 5. Inhibition of graft arteriosclerosis by modulation of the inflammatory response.
    Adams DH; Wyner LR; Steinbeck MJ; Karnovsky MJ
    Transplant Proc; 1993 Apr; 25(2):2092-4. PubMed ID: 8470282
    [No Abstract]   [Full Text] [Related]  

  • 6. Diagnostic criteria for chronic rejection/accelerated graft atherosclerosis in heart and kidney transplants: joint proposal from the Fourth Alexis Carrel Conference on Chronic Rejection and Accelerated Arteriosclerosis in Transplanted Organs.
    Paul LC; Hayry P; Foegh M; Dennis MJ; Mihatsch MJ; Larsson E; Fellström B
    Transplant Proc; 1993 Apr; 25(2):2022-3. PubMed ID: 8470261
    [No Abstract]   [Full Text] [Related]  

  • 7. Development of tolerance in a chronic rejection model.
    Tullius SG; Nieminen M; Bechstein WO; Jonas S; Rayes N; Qun Y; Volk HD; Neuhaus P
    Transplant Proc; 1998 Jun; 30(4):1075-6. PubMed ID: 9636436
    [No Abstract]   [Full Text] [Related]  

  • 8. Pathologic observations in human allograft recipients treated with FK 506.
    Demetris AJ; Fung JJ; Todo S; Banner B; Zerbe T; Sysyn G; Starzl TE
    Transplant Proc; 1990 Feb; 22(1):25-34. PubMed ID: 1689891
    [No Abstract]   [Full Text] [Related]  

  • 9. Effect of mycophenolate mofetil on allograft arteriosclerosis (chronic rejection).
    Räisänen-Sokolowski A; Myllärniemi M; Häyry P
    Transplant Proc; 1994 Dec; 26(6):3225. PubMed ID: 7998125
    [No Abstract]   [Full Text] [Related]  

  • 10. Comparison of rapamycin, RS 61443, cyclosporine, and low-dose heparin as treatment for transplant vasculopathy in a rat model of chronic allograft rejection.
    Schmid C; Heemann U; Azuma H; Tilney NL
    Transplant Proc; 1995 Feb; 27(1):438-9. PubMed ID: 7879053
    [No Abstract]   [Full Text] [Related]  

  • 11. Recurrent or persistent cardiac allograft rejection: therapeutic options and recommendations.
    Kirklin JK; Bourge RC; McGiffin DC
    Transplant Proc; 1997 Dec; 29(8A):40S-44S. PubMed ID: 9414674
    [No Abstract]   [Full Text] [Related]  

  • 12. Mycophenolate mofetil's effect on accelerated heart allograft rejection and rejection markers in the rat.
    Chen H; Qi S; Xu D; Wu J; Busque S; Daloze P
    Transplant Proc; 1998 Jun; 30(4):1049-50. PubMed ID: 9636424
    [No Abstract]   [Full Text] [Related]  

  • 13. Effect of low-molecular-weight heparin on development of cardiac allograft vascular disease following heart transplantation in rats.
    Hisatomi K
    Transplant Proc; 1998 Dec; 30(8):4337-9. PubMed ID: 9865378
    [No Abstract]   [Full Text] [Related]  

  • 14. Chronic rejection. A general overview of histopathology and pathophysiology with emphasis on liver, heart and intestinal allografts.
    Demetris AJ; Murase N; Lee RG; Randhawa P; Zeevi A; Pham S; Duquesnoy R; Fung JJ; Starzl TE
    Ann Transplant; 1997; 2(2):27-44. PubMed ID: 9869851
    [No Abstract]   [Full Text] [Related]  

  • 15. Experience in therapy of chronic liver allograft rejection.
    Charco R; Ruiz C; Allende E; Balsells J; Lazaro JL; Murio E; Bilbao I; Gifre E; Margarit C
    Transplant Proc; 1995 Aug; 27(4):2293-4. PubMed ID: 7652811
    [No Abstract]   [Full Text] [Related]  

  • 16. Herpes virus infections, acute rejection, and transplant arteriosclerosis in human cardiac allografts.
    Jäkel KT; Löning T
    Transplant Proc; 1993 Apr; 25(2):2029-30. PubMed ID: 8385831
    [No Abstract]   [Full Text] [Related]  

  • 17. An experimental model of chronic kidney allograft rejection under triple-drug treatment in the rat.
    Soots A; Lautenschlager I; Krogerus L; Saarinen O; Ahonen J
    Transplant Proc; 1997 Nov; 29(7):3152. PubMed ID: 9365704
    [No Abstract]   [Full Text] [Related]  

  • 18. The effect of differing immunosuppressive regimes on the functional and morphologic changes in a rat renal allograft model of chronic rejection.
    McGrath JS; Shehata M
    Transplant Proc; 2001 May; 33(3):2191-2. PubMed ID: 11377499
    [No Abstract]   [Full Text] [Related]  

  • 19. Effect of RS61443 on chronic rejection of rat kidney allografts.
    Azuma H; Binder J; Heemann U; Tullius SG; Tilney NL
    Transplant Proc; 1995 Feb; 27(1):436-7. PubMed ID: 7879052
    [No Abstract]   [Full Text] [Related]  

  • 20. Mechanisms of suppression of liver allograft rejection by LSF-1.
    Goto S; Vari F; Lord R; Edwards-Smith C; Chiba S; Kobayashi S; Pan TL; Lin YC; Chiang KC; Lai CY; Tatsuma T; Kitano S; Chen CL
    Transplant Proc; 1999; 31(1-2):451-2. PubMed ID: 10083184
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.